Wilson disease: genes and variants
Explore variant evidence for Wilson disease across 1 analyzed protein (ATP7B). Linked ClinVar records include 222 pathogenic or likely pathogenic variants, 828 variants of uncertain significance and 164 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Wilson disease
ATP7B: Copper-transporting ATPase 2
A copper-transporting ATPase that moves excess copper out of cells and helps deliver it from liver cells into bile. Its trafficking between intracellular membranes is central to copper homeostasis, and ATP7B dysfunction causes Wilson disease.
222 ClinVar pathogenic / likely pathogenic and 992 uncertain variants in ATP7B have source records linked to Wilson disease. Association strength is not clinical gene validity.
Where Wilson disease variants cluster
- ATP7B Cytoplasmic (positions 995–1322): 93 of 197 ClinVar pathogenic / likely pathogenic variants, 2.1× more than its size predicts (a length-based count, not a validated hotspot).
- ATP7B Transmembrane (positions 765–785): 18 of 197 ClinVar pathogenic / likely pathogenic variants, 6.4× more than its size predicts (a length-based count, not a validated hotspot).
- ATP7B Transmembrane (positions 973–994): 9 of 197 ClinVar pathogenic / likely pathogenic variants, 3.0× more than its size predicts (a length-based count, not a validated hotspot).
- ATP7B Transmembrane (positions 698–717): 8 of 197 ClinVar pathogenic / likely pathogenic variants, 3.0× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Wilson disease
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| ATP7B R616W | 616 | HMA 6 | Pathogenic / likely pathogenic (★★) |
| ATP7B D642H | 642 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B G691V | 691 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ATP7B G691R | 691 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ATP7B G710A | 710 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B G710S | 710 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B G711R | 711 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B G711W | 711 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B D765H | 765 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B D765G | 765 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B D765N | 765 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B T766R | 766 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B T766M | 766 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B P767L | 767 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B P768L | 768 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B R778Q | 778 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B R778W | 778 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B R778G | 778 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B W779G | 779 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B D829H | 829 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B A874V | 874 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B A874P | 874 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B T888P | 888 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B V890M | 890 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B S921R | 921 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B G943C | 943 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ATP7B G943D | 943 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ATP7B G943S | 943 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ATP7B G988R | 988 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B G988V | 988 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP7B V995A | 995 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B G998V | 998 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B A1003V | 1003 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B A1003T | 1003 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B K1010T | 1010 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B K1010R | 1010 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B A1018V | 1018 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B G1035V | 1035 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B R1041W | 1041 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B E1064K | 1064 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B E1064A | 1064 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B H1069Q | 1069 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B Q1095P | 1095 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B I1102T | 1102 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B V1146M | 1146 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B G1149R | 1149 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B T1178A | 1178 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B G1186R | 1186 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B G1186S | 1186 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B G1266R | 1266 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B D1267A | 1267 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B N1270I | 1270 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B N1270S | 1270 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B P1273Q | 1273 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B P1273L | 1273 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B D1279G | 1279 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B T1288R | 1288 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP7B G1341D | 1341 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ATP7B G1341S | 1341 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ATP7B D642Y | 642 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
Showing 60 of 222.
Uncertain variants prioritized for review in Wilson disease
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| ATP7B M1359I | 1359 | Transmembrane | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; M1359V at the same position is pathogenic; REVEL 0.968 |
| ATP7B S744F | 744 | Transmembrane | Conflicting reports (★) | +6: S744P at the same position is pathogenic; REVEL 0.950 |
| ATP7B P840T | 840 | Cytoplasmic | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; P840L at the same position is pathogenic; REVEL 0.970 |
| ATP7B T894I | 894 | Cytoplasmic | Conflicting reports (★) | +6: T894A at the same position is pathogenic; REVEL 0.943 |
| ATP7B A1074V | 1074 | Cytoplasmic | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; A1074T at the same position is pathogenic; REVEL 0.945 |
| ATP7B S1363C | 1363 | Transmembrane | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; S1363F at the same position is pathogenic; REVEL 0.927 |
| ATP7B G1030S | 1030 | Cytoplasmic | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; G1030D at the same position is pathogenic; REVEL 0.983 |
| ATP7B A1274V | 1274 | Cytoplasmic | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; A1274T at the same position is pathogenic; REVEL 0.917 |
| ATP7B T991M | 991 | Transmembrane | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; T991A at the same position is pathogenic; REVEL 0.927 |
| ATP7B G711E | 711 | Transmembrane | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; G711R at the same position is pathogenic; REVEL 0.968 |
| ATP7B T1288M | 1288 | Cytoplasmic | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; T1288P at the same position is pathogenic; REVEL 0.919 |
| ATP7B V1106D | 1106 | Cytoplasmic | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; V1106L at the same position is pathogenic; REVEL 0.962 |
| ATP7B S1067N | 1067 | Cytoplasmic | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; S1067R at the same position is pathogenic; REVEL 0.859 |
| ATP7B G1000V | 1000 | Cytoplasmic | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; G1000R at the same position is pathogenic; REVEL 0.867 |
| ATP7B R1151H | 1151 | Cytoplasmic | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; R1151C at the same position is pathogenic; REVEL 0.891 |
| ATP7B D829V | 829 | Cytoplasmic | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; D829H at the same position is pathogenic; REVEL 0.951 |
| ATP7B D829G | 829 | Cytoplasmic | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; D829H at the same position is pathogenic; REVEL 0.958 |
| ATP7B A1063V | 1063 | Cytoplasmic | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; A1063T at the same position is pathogenic; REVEL 0.837 |
| ATP7B R969W | 969 | Extracellular | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R969P at the same position is pathogenic; REVEL 0.849 |
| ATP7B M996T | 996 | Cytoplasmic | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; M996V at the same position is pathogenic; REVEL 0.928 |
| ATP7B G85D | 85 | HMA 1 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; G85V at the same position is pathogenic; REVEL 0.847 |
| ATP7B G922V | 922 | Transmembrane | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; G922R at the same position is pathogenic; REVEL 0.782 |
| ATP7B G85A | 85 | HMA 1 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; G85V at the same position is pathogenic; REVEL 0.799 |
| ATP7B T888S | 888 | Cytoplasmic | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; T888P at the same position is pathogenic; REVEL 0.856 |
| ATP7B I1230V | 1230 | Cytoplasmic | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; I1230L at the same position is pathogenic; REVEL 0.801 |
| ATP7B P1273S | 1273 | Cytoplasmic | Uncertain (★) | +6: 7 other pathogenic changes within 3 positions; P1273Q at the same position is pathogenic; REVEL 0.957 |
| ATP7B P840S | 840 | Cytoplasmic | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; P840L at the same position is pathogenic; REVEL 0.952 |
| ATP7B S1272C | 1272 | Cytoplasmic | Uncertain (★★) | +6: 7 other pathogenic changes within 3 positions; S1272Y at the same position is pathogenic; REVEL 0.910 |
| ATP7B R1151P | 1151 | Cytoplasmic | Uncertain (★★) | +6: 5 other pathogenic changes within 3 positions; R1151C at the same position is pathogenic; REVEL 0.894 |
| ATP7B A887P | 887 | Cytoplasmic | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; A887T at the same position is pathogenic; REVEL 0.882 |
| ATP7B C1079R | 1079 | Cytoplasmic | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; C1079F at the same position is pathogenic; REVEL 0.938 |
| ATP7B T601I | 601 | HMA 6 | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; T601A at the same position is pathogenic; REVEL 0.842 |
| ATP7B G614C | 614 | HMA 6 | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; G614D at the same position is pathogenic; REVEL 0.804 |
| ATP7B G1186A | 1186 | Cytoplasmic | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; G1186R at the same position is pathogenic; REVEL 0.809 |
| ATP7B A1003G | 1003 | Cytoplasmic | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; A1003P at the same position is pathogenic; REVEL 0.797 |
| ATP7B P768A | 768 | Transmembrane | Uncertain (★) | +6: 12 other pathogenic changes within 3 positions; P768R at the same position is pathogenic; REVEL 0.800 |
| ATP7B A604V | 604 | HMA 6 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; A604D at the same position is pathogenic; REVEL 0.785 |
| ATP7B M1025T | 1025 | Cytoplasmic | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; M1025K at the same position is pathogenic; REVEL 0.838 |
| ATP7B G1186D | 1186 | Cytoplasmic | Uncertain (★) | +6: 5 other pathogenic changes within 3 positions; G1186R at the same position is pathogenic; REVEL 0.778 |
| ATP7B A990S | 990 | Transmembrane | Uncertain (★★) | +6: 6 other pathogenic changes within 3 positions; A990P at the same position is pathogenic; REVEL 0.822 |
Which prediction tools work for Wilson disease
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 93 out of 100
- phyloP: 91 out of 100
- ESM1b (LLR): 91 out of 100
- PolyPhen-2: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 90 out of 100
- MetaSVM: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 82 out of 100
- SpliceAI: 49 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 38 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Wilson disease
- Hearing loss, also linked to ATP7B
- Hereditary breast ovarian cancer syndrome, also linked to ATP7B
Frequently asked questions
Which genes have records linked to Wilson disease?
This view contains 1 analyzed proteins: ATP7B. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 222 pathogenic or likely pathogenic variants, 828 variants of uncertain significance and 164 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 40 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 1,272 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center